Back to blog
Signal 28 Sep 2026 · 5 min read

Empirica Signal: Market Health | Sep 28, 2026 ·

This week's reading: hold fresh money, build the watchlist

Empirica Signal: Market Health | Sep 28, 2026 ·

The Nifty Smallcap 250 index has fallen below both its 10-day and 50-day average price, and it has crossed these two lines twice in the last 13 trading days. When the market keeps slipping back and forth across its own averages, it is running out of energy. Buyers are not strong enough to hold prices up.

Market condition this week: Condition 4, no fresh money deployment, and stay put.

Average price we track

Level (28 Sep 2026 close)

Index vs average

What it tells us

Index close

17,863

—

3.7% below its 52-week high of 18,551

5-day average

18,169

Below

Very short term: weak this week

10-day average

18,118

Below

Short-term push has faded

50-day average

18,214

1.9% below

Medium-term trend is under pressure

200-day average

16,853

6.0% above

Long-term trend is still intact

Nifty Smallcap 250 vs its averages · 28 Sep 2026 close, drawn to scale

Nifty Smallcap 250 vs its averages · 28 Sep 2026 close, drawn to scale

Our rule reads the 10-day and 50-day averages. The 5-day average gives early warning, and the 200-day average tells us whether the long-term uptrend is still in place. It is, so this is a pause to be careful in, not a reason to panic.

Why we watch the Nifty Smallcap 250

We invest mostly in companies with a market value between ₹2,000 crore and ₹30,000 crore. The Nifty Smallcap 250 index is made of exactly this kind of company. When it is healthy, the tide lifts our boats. When it is weak, even good companies find it hard to rise.

We read the index against four moving averages. A moving average is simply the average closing price over the last few days: the 10-day average is the average of the last 10 closes. It smooths out daily noise and shows the direction of travel. We check each one on the daily chart and on the weekly chart.

Average

Time it covers

The question it answers

5-day

About one trading week

Is the mood improving or worsening right now?

10-day

About two trading weeks

Do buyers have short-term control?

50-day

About two and a half months

Is the medium-term trend up?

200-day

About ten months

Is the long-term trend up?

Track the index yourself: Nifty Smallcap 250 chart on TradingView.

Our rulebook: four market conditions

Where the index closes against its 10-day and 50-day averages puts the market in one of four conditions. Each one tells us how we treat fresh money.

Where the index closes vs its 10-day and 50-day averages · four conditions

Where the index closes vs its 10-day and 50-day averages · four conditions

Condition

Index vs 10-day

Index vs 50-day

What we do with fresh money

1

Above

Above

Buy our shortlisted companies once we find a good entry point. A healthy market.

2

Above

Below

Buy only companies whose price is stronger than the index, at a good entry point.

3

Below

Above

Same as condition 2. Last week we bought Spectrum Electrical Industries under this rule; the full report comes out this Sunday.

4

Below

Below

No fresh money. Build and study watchlists of companies showing strength against the index.

Conditions 2 and 3 are not normal buying markets. The direction is unclear, so each company has to earn its place by beating the index first.

Relative strength: is the company beating the market?

Relative strength compares a company's share price with the index, every day. We divide the stock price by the index price and plot the result as a line. Only the direction of that line matters, not its value.

{Relative strength} = {Stock price}/{Index price}

If the line rises, the stock is doing better than the market. If it falls, the stock is doing worse, even when its own price is going up.

Four shapes of the relative strength line

Four shapes of the relative strength line

We track this line on three charts:

Chart

What it shows

How we use it

Daily

The last few weeks

Timing a good entry point

Weekly

The last several months

Confirming the trend is real

Monthly

The last few years

Checking the long-term leadership story

The strongest case is a line rising on all three charts. A stock that holds up while the index falls, as it is doing now, is showing its hand early.

What we are doing this week

With the index in condition 4, fresh money waits. We keep working: this is when the buy list for the next upturn gets built.

  1. Pause fresh buying. No new money into equities until the index closes back above its 10-day and 50-day averages, or a company clears the relative strength test on its own.

  2. Scan for relative strength. We go through our older watchlists and flag companies whose relative strength line is rising while the index falls.

  3. Check the business. Every flagged company goes through our usual review of earnings, balance sheet, management and valuation. Price strength without a real business behind it does not make the list.

  4. Mark the entry points. For each company that passes, we note the price levels where we would act once the market turns healthy again.

What would change our view: the index closing back above both its 10-day and 50-day averages, and holding there instead of slipping back as it did twice this month. We will report it here the week it happens.

Written by Uddeshya Goel, CFA. This post is for education and explains the framework Empirica India uses internally. It is not a recommendation to buy or sell any security. Market levels are as of the close on 28 September 2026 and will change. Past patterns do not guarantee future results. Please consult your own adviser before investing.

 

More from the blog

Why GMM Pfaudler Is On Our Watchlist
Selection 26 Sep 2026 · 24 min read

Why GMM Pfaudler Is On Our Watchlist

The largest maker of corrosion-proof process equipment in the world spent three years going nowhere. Sales stopped growing. Reported profit fell by more than three quarters. The share price halved. Underneath all of that, the company was quietly generating more spare cash every single year ₹367 crore last year against ₹52 crore of reported profit. Its order book has just reached an all-time high, and the share price has broken out to a new high.

Read more